Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Global resurgence in zoonotic viral diseases

Doctors and veterinarians need to work together to tackle the increasing global threat of zoonotic viral diseases spread by non-human vertebrate hosts - including dogs, cattle, chickens and mosquitoes - according to a review in the November issue of Journal of Internal Medicine.

8 Nov 2006

Chinese bird flu expert will head the WHO

Dr. Margaret Chan, a Chinese expert on bird flu, is to be the next head of the World Health Organization (WHO).

8 Nov 2006

Chronic fatigue syndrome a public health epidemic says CDC

The Centers for Disease Control and Prevention (CDC) in the United States says more than a million Americans suffer from Chronic fatigue syndrome (CFS).

6 Nov 2006

Stay cool and live longer!

If new research is to be believed living longer may simply be a case of staying cool.

6 Nov 2006

WHO has a go at China over new birdflu strain

The World Health Organisation (WHO) says the new strain of the H5N1 bird flu virus currently circulating in China has shown no significant signs of mutation which would enable it to spread easily among people.

6 Nov 2006

Doctors worried about dramatic rise of TB in the UK

Experts have expressed concern over the steady rise in Tuberculosis (TB) in the last seven years in Britain.

6 Nov 2006

Salmonella traced to tomatoes

Health officials in the U.S. say that the recent outbreak of Salmonella food poisoning there probably came tomatoes which were served in restaurants.

6 Nov 2006

For divorced women health pays the price ten years down the line

A 10-year study by researchers at Iowa State University has revealed that women who divorce give up more than just a husband.

2 Nov 2006

Chinese lack of transparency could trigger bird flu pandemic

The transparency of health authorities in China has come under criticism yet again with the news of a new strain of the deadly H5N1 bird flu virus which virologists say could be resistant to vaccines.

1 Nov 2006

Weill Cornell findings could foil two potential bioterror agents - viral peptide prevents deadly Hendra, Nipah viruses from infecting cells

Two lethal and easily transmitted viruses -- both potential bioterror agents -- may soon be much less dangerous, thanks to research led by scientists at Weill Cornell Medical College in New York City.

31 Oct 2006

Rogue bird flu resistant to vaccines

Researchers in Hong Kong and the U.S. say a new strain of the H5N1 bird flu virus has emerged in China and what is more of a worry is the strain appears to be resistant to vaccines.

31 Oct 2006

What will Americans do if bird flu strikes?

According to a recent poll most Americans would comply with government orders to avoid work, school or other public places in the event of a flu pandemic.

30 Oct 2006

GSK about to sign another big bird flu deal

Europe's largest drug maker GlaxoSmithKline is said to be about to sign another deal to provide tens of millions of doses of it's experimental H5N1 vaccine for humans.

30 Oct 2006

Expert says flu vaccination programs a pointless waste of money

According to a vaccine expert the millions spent on flu vaccination programs each year are a waste of time and money.

30 Oct 2006

In the case of an outbreak of pandemic flu, large majority of Americans willing to make major changes in their lives

The latest national survey conducted by the Harvard School of Public Health (HSPH) Project on the Public and Biological Security finds that when faced with a serious outbreak of pandemic flu, a large majority of Americans are willing to make major changes in their lives and cooperate with public health officials' recommendations.

26 Oct 2006

Wal-Mart expands generic prescription drug discount program

Wal-Mart Stores on Thursday announced plans to expand a generic prescription drug discount program introduced last month to 12 additional states, the AP/Houston Chronicle reports (AP/Houston Chronicle, 10/26).

26 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006